Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats

Table 3 Endothelial factors of different treatment (mean ± SD) (n = 8, each)

YXC (g/kg)	Swimming (h)	NO (pg/ml)		ET (pg/ml)		TXB₂(pg/ml)		6-keto-PGF_1α(pg/ml)
0	0	16.80 ± 3.99		69.54 ± 9.58		361.91 ± 56.38		57.08 ± 12.57
0	0.5	22.67 ± 4.28		60.32 ± 9.99		207.85 ± 66.03		84.86 ± 32.33
0	1	24.38 ± 4.47		66.04 ± 8.25		326.70 ± 155.64		78.76 ± 31.82
1	0	40.38 ± 7.61		73.21 ± 5.25		531.44 ± 126.99		65.84 ± 25.92
1	0.5	32.00 ± 9.56		60.21 ± 5.13		167.76 ± 86.16		63.27 ± 16.27
1	1	33.07 ± 8.07		65.16 ± 9.22		345.63 ± 139.01		69.27 ± 17.32
2	0	39.62 ± 6.61		53.55 ± 8.82		362.03 ± 76.92		105.91 ± 28.86
2	0.5	42.29 ± 12.83		62.75 ± 6.91		385.41 ± 157.32		85.35 ± 16.71
2	1	36.19 ± 6.51		64.14 ± 8.30		212.34 ± 90.98		45.26 ± 17.28
Two-way ANOVA		F	P	F	P	F	P	F	P
YXC		37.361	0.000	3.642	0.330	0.778	0.466	1.544	0.224
Swimming		0.162	0.851	1.868	0.164	8.018	0.001	2.150	0.127
YXC × Swimming		3.142	0.020	4.418	0.004	5.479	0.001	6.322	0.001

All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergism effect. Comparisons between each pair of factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 was considered statistically significant.

ISSN: 2662-7671